Investment ThemesDetailed Quotes
CAR-T Therapy
Watchlist
- 1089.196
- -0.130-0.01%
Trading Oct 15 09:37 ET
1089.196High1084.481Low
1088.794Open1089.326Pre Close3.19MVolume5Rise17.06P/E (Static)259.31MTurnover--Flatline0.02%Turnover Ratio1.17TMarket Cap5Fall1.15TFloat Cap
Constituent Stocks: 10Top Rising: ADAP+2.28%
Let's take a closer look. Compared to the 2 previous small peaks, there is a trading volume decline and a neutral RSI indicator (low volitility, neither overbought nor oversold). There are no signals for up or down trend here.
Trendline also does not give a clear ...
$Iterum Therapeutics (ITRM.US)$ : 🤔
⇨ Oral Sulopenem
‣ Uncomplicated Urinary Tract Infections
‣ PDUFA: 10/25/24
$Lexicon Pharmaceuticals (LXRX.US)$ : [Adcom] 🤔
⇨ ZYNQUISTA (sotagliflozin)
‣ Type 1 Diabetes
‣ Adcom: 10/31/24
📣 Last Week’s PDUFA Decisions:
$ZLDPF: CRL 10/8 ❌
⚠️ due to timing of a 3rd-party mfg. facility reinspection
⇨ Dasiglucagon
‣ Congenital Hyperinsulinism
‣ PDUFA: 10/08/24 (NDA)
$RRBHY: Approved 10/11 ✅
⇨ Itovebi™ (inavolis...
Please find the following performance report of W2 of Oct.
Also here is the asset distribution pie chart.
As can be seen above, over 50% completely depends on SOXL, yet I have started hedging through SOXS (15%) currently doing DCA.
I will also attache my whole portfolio as below.
I am glad that some of my early entries, such as Pepsi, Ford, and Amazon, have become reasonable.
Overall, nothing have happened this week in terms o...
loading...
The current bull market has hit almost 2 years.
With inflation falling, Fed cutting rates and corporate earnings looking decent, will the bulls march into Santa rally and into 2025?
$LVMH Moet Hennessy Louis Vuitton (LVMUY.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Salesforce (CRM.US)$ $Snap Inc (SNAP.US)$ $Spotify Technology (SPOT.US)$ $GameStop (GME.US)$ $Johnson & Johnson (JNJ.US)$ $Morgan Stanley (MS.US)$ $Financial Select Sector SPDR Fund (XLF.US)$ $Spdr S&P Bank Etf (KBE.US)$ $U.S. 10-Year Treasury Notes Yield (US10Y.BD)$ $SPDR Gold ETF (GLD.US)$ $Coca-Cola (KO.US)$ $Starbucks (SBUX.US)$
Pfizer has announced the approval of HYMPAVZI (marstacimab-hncq) by the US Food and Drug Administration (FDA) for routine prophylaxis in patients with haemophilia A and B.
HYMPAVZI, a rebalancing agent that targets the tissue factor pathway inhibitor’s (TFPI) Kunitz 2 domain, offers a once-weekly subcutaneous treatment option. TFPI is a natural anticoagulant protein that helps to prevent blood clot formation and restore haemostasis.
Goldman Sachs, Morgan Stanley, Citigroup, and other top financial firms are scheduled to report earnings this week.
Investors will also get financial updates from UnitedHealth Group, Johnson & Johnson, and Intuitive Surgical, while Taiwan Semiconductor Manufacturing and Netflix also will issue earnings this week.
Retail sales, housing starts, building permits, and homebuilder confidence are also on tap this week.
Bond markets are closed for t...
No comment yet